Taken together, our data have disclosed NDFIP1 as a novel tumor suppressor and proposed a new exosome-related regulatory mechanism of TAZ, providing new insights for the development of biomarkers and treatment strategies of NSCLC. Here, NDFIP1 is linked to non-small cell lung carcinoma.